FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067087 [Registered on: 09/05/2024] Trial Registered Prospectively
Last Modified On: 07/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   cardiovascular risk prediction as per prakriti 
Scientific Title of Study   DETERMINATION OF THE RISK PREDICTION OF CARDIOVASCULAR DISEASE AS PER PRAKRITI AMONG PATIENTS OF DIABETES MELLITUS type-2 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubham Maharana 
Designation  PG Scholar 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  PG Department of Kriyasharir, Chaudhary Brahm Prakash ayurved Charak Sansthan, Khera Dabar South West DELHI 110073 India South West DELHI 110073 India

South West
DELHI
110073
India 
Phone  7008932094  
Fax    
Email  smaharana243@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rakesh Roushan 
Designation  Assistant Professor 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  PG Department of Kriyasharir, Chaudhary Brahm Prakash ayurved Charak Sansthan, Khera Dabar South West DELHI 110073 India South West DELHI 110073 India

South West
DELHI
110073
India 
Phone  9136226421  
Fax    
Email  rakesh3151@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rakesh Roushan 
Designation  Assistant Professor 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  PG Department of Kriyasharir, Chaudhary Brahm Prakash ayurved Charak Sansthan, Khera Dabar South West DELHI 110073 India South West DELHI 110073 India


DELHI
110073
India 
Phone  9136226421  
Fax    
Email  rakesh3151@gmail.com  
 
Source of Monetary or Material Support  
Chaudhary Brahm Prakash ayurved Charak Sansthan,kheda dabur ,najafgarh,new delhi,pincode-767001 
 
Primary Sponsor  
Name  Chaudhary Brahm Prakash ayurved Charak Sansthan 
Address  Chaudhary Brahm Prakash ayurved Charak Sansthan, Khera Dabar South West DELHI 110073 India South West DELHI 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr shubham maharana  Chaudhary Brahm Prakash ayurved Charak Sansthan  PG Department of Kriyasharir, Chaudhary Brahm Prakash ayurved Charak Sansthan, Khera Dabar South West DELHI 110073 India
South West
DELHI 
7008932094

smaharana243@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-CBPACS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E118||Type 2 diabetes mellitus with unspecified complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1 Individuals of both sexes with or without associated risk factors.
2 Individuals willing to participate in this study and has given his consent.
3 Individuals having no history of any apparent disease in last one month.
 
 
ExclusionCriteria 
Details  No past history of cardiovascular events namely Coronary heart disease Stroke etc at the time of enrolment or no evidence of past cardiovascular event and other Individuals with known risk factors on evaluation shown evidence of cardiovascular complications 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to rule out different risk factors of cardiovascular diseases with different ayurvedic prakritis among the patients of type 2 diabetes mellitus  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="127"
Sample Size from India="127" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Diabetes is brought on by either insufficient insulin production by the pancreas or inefficient insulin use by the body. A hormone called insulin controls blood sugar levels. Uncontrolled diabetes frequently causes hyperglycemia, also known as high. blood glucose, which over time can seriously harm many different bodily systems, including the neurons and blood vessels. Atherosclerosis is the most common complication of diabetes. Epidemiologic and pathophysiologic evidence suggest a number of possible reasons for this. They include alterations in lipoproteins, platelets, soluble clotting factors, the balance of prostacyclin-thromboxane, blood pressure regulation, and arterial smooth muscle cell metabolism and proliferation. Dysfunction of the vascular endothelium is a hallmark of most conditions that are associated with both diabetes and atherosclerosis. Although the pathological link between diabetes and atherosclerosis is well-established, better comprehension of the underlying mechanisms is of utmost importance to identify novel potential molecular targetsFor this a score predictor called ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American College of Cardiology. It is a calculation of coming 10-year risk of having a cardiovascular problem, such as a heart attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use, diabetic status, and smoking status.
Prakriti means nature, character and constitution of a person which remains within our self from birth to till death. Prakriti never changes. This constitution comprises of both “physical body” as well as “mental body”.Prakriti is the manifestation of special characteristics due to predominance of Doshas (Vata, Pitta and Kapha the functional component of body), & in these Prakriti indicates predominance of specific Dosha in a human being. There are pre-natal and post-natal factors which also determine the constitution of a body in minor way. Involvement of Dosha in Prakriti formation may be individual or intermingled. So, Prakriti is of seven types, i.e. Vataj, Pittaj, shaleshmaj, Vatajapittaaj, pittajashleshmaj, shleshmajavataj and one Samadoshaj. Among these, Samadoshaj is considered as an excellent 

RESEARCH QUESTION

Does risk of cardiovascular disease (CVD) is associated with Prakriti among patients of type II  diabetes mellitus to those who do not?

HYPOTHESIS

NULL HYPOTHESIS (Ho): Prakriti is not associated with the risk factor of CVD among type II diabetes patients

ALTERNATE HYOPTHESIS (HA): Prakriti is associated with the risk factor of CVD among type II diabetes patients

AIM:To determine the risk of cardiovascular diseases as per Prakriti among patients of Type II  diabetes mellitus to those who do not by using Atherosclerotic Cardiovascular Disease Score (ASCSVD).

PRIMARY OBJECTIVE:Determine the effect of Type II Diabetes Mellitus on cardiovascular disease as per Prakriti by using atherosclerotic cardiovascular disease (ASCVD) score among patients of diabetes mellitus to those who do not.

SECONDARY OBJECTIVE:To find the association of other risk factors for developing cardiovascular diseases by using ASCVD score.

 
Close